• Je něco špatně v tomto záznamu ?

Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition

T. Kováčová, P. Souček, P. Hujová, T. Freiberger, L. Grodecká

. 2020 ; 21 (18) : . [pub] 20200908

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012154

Grantová podpora
NU20-02-00261 Ministerstvo Zdravotnictví Ceské Republiky
201904 Centre for Cardiovascular Surgery and Transplantation
MUNI/A/1099/2019 Ministerstvo Školství, Mládeže a Tělovýchovy

Acceptor splice site recognition (3' splice site: 3'ss) is a fundamental step in precursor messenger RNA (pre-mRNA) splicing. Generally, the U2 small nuclear ribonucleoprotein (snRNP) auxiliary factor (U2AF) heterodimer recognizes the 3'ss, of which U2AF35 has a dual function: (i) It binds to the intron-exon border of some 3'ss and (ii) mediates enhancer-binding splicing activators' interactions with the spliceosome. Alternative mechanisms for 3'ss recognition have been suggested, yet they are still not thoroughly understood. Here, we analyzed 3'ss recognition where the intron-exon border is bound by a ubiquitous splicing regulator SRSF1. Using the minigene analysis of two model exons and their mutants, BRCA2 exon 12 and VARS2 exon 17, we showed that the exon inclusion correlated much better with the predicted SRSF1 affinity than 3'ss quality, which were assessed using the Catalog of Inferred Sequence Binding Preferences of RNA binding proteins (CISBP-RNA) database and maximum entropy algorithm (MaxEnt) predictor and the U2AF35 consensus matrix, respectively. RNA affinity purification proved SRSF1 binding to the model 3'ss. On the other hand, knockdown experiments revealed that U2AF35 also plays a role in these exons' inclusion. Most probably, both factors stochastically bind the 3'ss, supporting exon recognition, more apparently in VARS2 exon 17. Identifying splicing activators as 3'ss recognition factors is crucial for both a basic understanding of splicing regulation and human genetic diagnostics when assessing variants' effects on splicing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012154
003      
CZ-PrNML
005      
20210507102708.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21186553 $2 doi
035    __
$a (PubMed)32911621
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kováčová, Tatiana $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, 656 91 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
245    10
$a Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition / $c T. Kováčová, P. Souček, P. Hujová, T. Freiberger, L. Grodecká
520    9_
$a Acceptor splice site recognition (3' splice site: 3'ss) is a fundamental step in precursor messenger RNA (pre-mRNA) splicing. Generally, the U2 small nuclear ribonucleoprotein (snRNP) auxiliary factor (U2AF) heterodimer recognizes the 3'ss, of which U2AF35 has a dual function: (i) It binds to the intron-exon border of some 3'ss and (ii) mediates enhancer-binding splicing activators' interactions with the spliceosome. Alternative mechanisms for 3'ss recognition have been suggested, yet they are still not thoroughly understood. Here, we analyzed 3'ss recognition where the intron-exon border is bound by a ubiquitous splicing regulator SRSF1. Using the minigene analysis of two model exons and their mutants, BRCA2 exon 12 and VARS2 exon 17, we showed that the exon inclusion correlated much better with the predicted SRSF1 affinity than 3'ss quality, which were assessed using the Catalog of Inferred Sequence Binding Preferences of RNA binding proteins (CISBP-RNA) database and maximum entropy algorithm (MaxEnt) predictor and the U2AF35 consensus matrix, respectively. RNA affinity purification proved SRSF1 binding to the model 3'ss. On the other hand, knockdown experiments revealed that U2AF35 also plays a role in these exons' inclusion. Most probably, both factors stochastically bind the 3'ss, supporting exon recognition, more apparently in VARS2 exon 17. Identifying splicing activators as 3'ss recognition factors is crucial for both a basic understanding of splicing regulation and human genetic diagnostics when assessing variants' effects on splicing.
650    _2
$a alternativní sestřih $x genetika $7 D017398
650    _2
$a sekvence nukleotidů $x genetika $7 D001483
650    _2
$a exony $x genetika $7 D005091
650    _2
$a HeLa buňky $7 D006367
650    _2
$a lidé $7 D006801
650    _2
$a introny $x genetika $7 D007438
650    _2
$a místa sestřihu RNA $x genetika $x fyziologie $7 D022821
650    _2
$a sestřih RNA $x fyziologie $7 D012326
650    _2
$a sestřihové faktory $x metabolismus $x fyziologie $7 D000072260
650    _2
$a proteiny vázající RNA $x metabolismus $7 D016601
650    _2
$a regulační oblasti nukleových kyselin $x genetika $7 D012045
650    _2
$a serin-arginin sestřihové faktory $x metabolismus $7 D000068103
650    _2
$a spliceozomy $x metabolismus $7 D017381
650    _2
$a sestřihový faktor U2AF $x metabolismus $7 D000072668
655    _2
$a časopisecké články $7 D016428
700    1_
$a Souček, Přemysl $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, 656 91 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Hujová, Pavla $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, 656 91 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Freiberger, Tomáš $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, 656 91 Brno, Czech Republic $u Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic
700    1_
$a Grodecká, Lucie $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, 656 91 Brno, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 18 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32911621 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102707 $b ABA008
999    __
$a ok $b bmc $g 1650513 $s 1132533
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 18 $e 20200908 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a NU20-02-00261 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a 201904 $p Centre for Cardiovascular Surgery and Transplantation
GRA    __
$a MUNI/A/1099/2019 $p Ministerstvo Školství, Mládeže a Tělovýchovy
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...